Par installs Pera as commercial head

Share this article:

Par Pharmaceuticals named Antonio Pera as chief commercial officer. Pera previously worked as SVP, commercial operations, JHP Pharmaceuticals, which was acquired by Par at the end of January. In his new role, Pera will manage the organization's relationships with major trade partners.

Pera also worked at AmeriSourceBergen as SVP, supply chain management.

"He has a demonstrated expertise in the marketing, sales and distribution of generic drugs," stated Paul Campanelli, CEO of Par, adding, “We look forward to the leadership Tony will provide our commercial organization and the many contributions he will make to our company."

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.